• 1
    Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 38391.
  • 2
    Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128: S3846.
  • 3
    Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 112933.
  • 4
    Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ III. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 2003; 1: 1927.
  • 5
    Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007; 102: 145460.
    Direct Link:
  • 6
    Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 28692.
  • 7
    Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 251724.
  • 8
    West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 9605.
  • 9
    Bingley PJ, Williams AJ, Norcross AJ, et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004; 328: 3223.
  • 10
    Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 91120.
  • 11
    Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J. The execution of the Mini-Finland Health Survey. Part 1: Aims, methods and study population (in Finnish with English summary). Vol. 1. Helsinki and Turku: The Social Insurance Institution, 1989.
  • 12
    Lehtonen R, Kuusela V. The execution of the Mini-Finland Health Survey. Part 5: Statistical efficiency of the Mini-Finland Health Survey′s sampling design (in Finnish with English summary). Vol. 5. Helsinki and Turku: The Social Insurance Institution, 1986.
  • 13
    Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Available at: Accessed April 18, 2007.
  • 14
    Zone JJ. Skin manifestations of celiac disease. Gastroenterology 2005; 128: S8791.
  • 15
    Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 90911.
  • 16
    Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 13228.
  • 17
    Stern M, Working Group on Serologic Screening for Celiac Disease. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr 2000; 31: 5139.
  • 18
    Research Triangle Institute. SUDAAN Language Manual, Release 9.0. Research Triangle Park, NC: Research Triangle Institute, 2004.
  • 19
    Korn EL, Graubard BI. Analysis of health surveys. New York: John Wiley & Sons, 1999.
  • 20
    Iltanen S, Holm K, Partanen J, Laippala P, Mäki M. Increased density of jejunal gammadelta+ T cells in patients having normal mucosa--marker of operative autoimmune mechanisms? Autoimmunity 1999; 29: 17987.
  • 21
    Salmi TT, Collin P, Jarvinen O, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006; 24: 54152.
  • 22
    Fry L, Seah PP, McMinn RM, Hoffbrand AV. Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J 1972; 3: 3714.
  • 23
    Reunala T, Kosnai I, Karpati S, Kuitunen P, Torok E, Savilahti E. Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. Arch Dis Child 1984; 59: 51722.
  • 24
    Kaukinen K, Maki M, Partanen J, Sievanen H, Collin P. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001; 46: 87987.
  • 25
    Tursi A, Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 2003; 36: 137.
  • 26
    Dickey W, Hughes DF, McMillan SA. Patients with serum IgA endomysial antibodies and intact duodenal villi: clinical characteristics and management options. Scand J Gastroenterol 2005; 40: 12403.
  • 27
    Kaukinen K, Peraaho M, Collin P, et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005; 40: 56472.
  • 28
    Paparo F, Petrone E, Tosco A, et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol 2005; 100: 22948.
    Direct Link:
  • 29
    Mäki M, Holm K, Lipsanen V, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet 1991; 338: 13503.
  • 30
    Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004; 49: 54650.
  • 31
    Carroccio A, Giannitrapani L, Soresi M, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 2001; 49: 50611.
  • 32
    Peracchi M, Trovato C, Longhi M, et al. Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 2002; 97: 28504.
    Direct Link:
  • 33
    Kosunen TU, Hook-Nikanne J, Salomaa A, Sarna S, Aromaa A, Haahtela T. Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy 2002; 32: 3738.
  • 34
    Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T. Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol 2000; 106: 24752.
  • 35
    Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician’s alertness to the condition essential. J Clin Gastroenterol 2007; 41: 1526.
  • 36
    Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 86977.
  • 37
    Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease--an extended version. J Pediatr Gastroenterol Nutr 2004; 38: 37888.
  • 38
    Mäki M, Kallonen K, Lahdeaho ML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand 1988; 77: 40812.
  • 39
    Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75: 91421.
  • 40
    Norris JM, Barriga K, Hoffenberg EJ, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005; 293: 234351.
  • 41
    Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 2006; 91: 3943.
  • 42
    Cronin CC, Shanahan F. Why is celiac disease so common in Ireland? Perspect Biol Med 2001; 44: 34252.
  • 43
    Somersalo O. Studies of childhood diabetes. I. Incidence in Finland. Ann Paediatr Fenn 1954; 1: 23949.
  • 44
    Reunanen A, Åkerblom HK, Käär ML. Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. Acta Paediatr Scand 1982; 71: 8939.